Lt Foods (LTFOODS.NS) traded down -1.34 % during a 24 hours period ending at 03:30 PM Central Europe on Monday 26th. One Lt Foods stock can currently be bought for about INR 382.2 on popular exchanges. Current supply of Lt Foods stocks is 347.3 mn. Lt Foods has a current market capitalization of INR 131.9 bn and approximately INR 143.8 mn worth of Lt Foods was traded on exchanges in the last 24 hours. Since last month end, Lt Foods has traded -10.52 % down. Simple moving average of last 200 days is at INR 401.43. The highest price of past 52 weeks was recorded at INR 490.7 on 08/24/2026. 52 weeks low was at INR 333.15 on 01/20/2026.
Here is how related stocks have performed in the past 24 hours:
Choice (CHOICEIN.NS) traded down -3.83 % and now trades at INR 698.05. Choice has a market capitalisation of INR 153 bn. Current price/earnings ratio for Choice is 67.43.
Jsw Cement (JSWCEMENT.NS) traded up 2 % and now trades at INR 117.6. Jsw Cement has a market capitalisation of INR 158.2 bn. Current price/earnings ratio for Jsw Cement is 20.08. JSW Cement has experienced a period of consolidation after a recent corrective movement from a higher price zone. Technical analysis suggests the stock has regained its 20‑day moving average and its short‑term momentum indicator has turned positive, hinting at a potential rebound from oversold conditions. Analysts view the current price level as a possible base for a recovery, provided the momentum remains sustained and the broader market environment supports an upward shift. The outlook remains cautious, with the emphasis on monitoring short‑term technical cues before committing to a buying stance.
Eris Lifesciences (ERIS.NS) traded down -2.29 % and now trades at INR 1,105.2. Eris Lifesciences has a market capitalisation of INR 152 bn. Current price/earnings ratio for Eris Lifesciences is 24.31. Eris Lifesciences Ltd. reported its latest quarterly results on 26 October, following a review of the period ending 30 September. The company’s earnings per share were expected to rise modestly compared with the prior year, while analysts anticipated a similar lift in revenue. Forecasts for the current fiscal year suggest a slight improvement in both earnings per share and overall sales relative to the previous year. The company’s financial performance was highlighted alongside other listed firms in a broader market update, which noted that several companies were set to release earnings on that day. No significant strategic announcements or corporate actions were disclosed by Eris Lifesciences beyond the standard quarterly reporting.
Beml (BEML.NS) traded down -2.96 % and now trades at INR 1,844.6. Beml has a market capitalisation of INR 154.2 bn. Beml has a current price to earnings ratio of 88.17.
Alivus Life Sciences (ALIVUS.NS) traded down -1.45 % and now trades at INR 1,262. Current market capitalisation for Alivus Life Sciences is INR 153.5 bn. Alivus Life Sciences has a current price to earnings ratio of 25.66.